Interacciones de Tafenoquina

Tafenoquina (Krintafel, Arakoda), antipalúdico, tiene 34 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 12; moderadas: 19; leves: 3; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (12)

  • Alogliptina y metforminainhibidor de la DPP-4Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Dapagliflozina y metforminainhibidor de SGLT2Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • DofetilidaantiarrítmicoGrave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Empagliflozina y metforminainhibidor de SGLT2Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Glipizida y metforminasulfonilureaGrave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Linagliptina y metforminainhibidor de la DPP-4Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • MetforminabiguanidaGrave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Penicillamine should not be used in patients who are receiving concurrently gold therapy, antimalarial or cytotoxic drugs, oxyphenbutazone or phenylbutazone because these drugs are also associated with similar serious hematologic and renal adverse reactions. (etiqueta de Penicilamina, Precauciones)

  • Pioglitazona y metforminatiazolidinedionaGrave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Saxagliptina y metforminainhibidor de la DPP-4Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

  • Sitagliptina y metforminainhibidor de la DPP-4Grave

    Avoid coadministration of ARAKODA with OCT2 and MATE substrates (e.g., dofetilide, metformin). (etiqueta de Tafenoquina, Interacciones medicamentosas)

Interacciones moderadas (19)

  • Articaína y adrenalinaanestésico localModerada

    …ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase… (etiqueta de Articaína y adrenalina, Interacciones medicamentosas)

  • Bupivacaínaanestésico localModerada

    • Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (etiqueta de Bupivacaína, Interacciones medicamentosas)

  • Bupivacaína y adrenalinaanestésico localModerada

    • Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (etiqueta de Bupivacaína y adrenalina, Interacciones medicamentosas)

  • Cloroprocaínaanestésico localModerada

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (etiqueta de Cloroprocaína, Precauciones)

  • CloroquinaantipalúdicoModerada

    Patients infected with a resistant strain of plasmodia as shown by the fact that normally adequate doses have failed to prevent or cure clinical malaria or parasitemia should be treated with another form of antimalarial therapy. (etiqueta de Cloroquina, Advertencias)

  • DarunavirantirretroviralModerada

    Antimalarial : artemether/lumefantrine ↓ artemether ↓ dihydroartemisinin ↑ lumefantrine ↔ darunavir The combination of PREZISTA/ritonavir and artemether/lumefantrine can be used without dose adjustments. (etiqueta de Darunavir, Interacciones medicamentosas)

  • Darunavir y cobicistatantirretroviralModerada

    Antimalarial: artemether/lumefantrine artemether: effect unknown lumefantrine: effect unknown Monitor for a potential decrease of antimalarial efficacy or potential QT prolongation. (etiqueta de Darunavir y cobicistat, Interacciones medicamentosas)

  • Droperidolantagonista de la dopaminaModerada

    Possible pharmacodynamic interactions can occur between droperidol and potentially arrhythmogenic agents such as class I or III antiarrhythmics, antihistamines that prolong the QT interval, antimalarials, calcium channel blockers, neuroleptics that prolong the QT interval, and antidepressants. (etiqueta de Droperidol, Interacciones medicamentosas)

  • EfavirenzantirretroviralModerada

    Antimalarials: Artemether/lumefantrine Atovaquone/ proguanil ↓ artemether * ↓ dihydroartemisinin * ↓ lumefantrine * ↓ atovaquone ↓ proguanil Consider alternatives to artemether/ lumefantrine because of the risk of QT interval prolongation. (etiqueta de Efavirenz, Interacciones medicamentosas)

  • Efavirenz, lamivudina y tenofovirantirretroviralModerada

    Antimalarials: Artemether/lumefantrine ↓ artemether ↓ dihydroartemisinin ↓ lumefantrine Consider alternatives to artemether/lumefantrine because of the risk of QT interval prolongation [see Warnings and Precautions (5.16) ] . (etiqueta de Efavirenz, lamivudina y tenofovir, Interacciones medicamentosas)

  • EtravirinaantirretroviralModerada

    Antimalarial : artemether/lumefantrine ↔ etravirine ↓ artemether ↓ dihydroartemisinin ↓ lumefantrine Caution is warranted when co-administering Etravirine and artemether/lumefantrine as it is unknown whether the decrease in exposure of artemether or its active metabolite, dihydroartemisinin, could result in decreased antimalarial efficacy. (etiqueta de Etravirina, Interacciones medicamentosas)

  • Hidroxicloroquinafármaco que prolonga el intervalo QTModerada

    Co-administration of PLAQUENIL with other antimalarials known to lower the seizure threshold (e.g., mefloquine) may increase the risk of seizures. (etiqueta de Hidroxicloroquina, Interacciones medicamentosas)

  • Lidocaína y adrenalinaanestésico localModerada

    Drugs Associated with Methemoglobinemia: Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs. (etiqueta de Lidocaína y adrenalina, Interacciones medicamentosas)

  • Lidocaína y prilocaínaanestésico localModerada

    …prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sufonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (etiqueta de Lidocaína y prilocaína, Interacciones medicamentosas)

  • MefloquinaantipalúdicoModerada

    Other Antimalarial Drugs Concomitant administration of mefloquine and other related antimalarial compounds (e.g., quinine, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions (see WARNINGS ). (etiqueta de Mefloquina, Interacciones medicamentosas)

  • Mepivacaínaanestésico localModerada

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (etiqueta de Mepivacaína, Interacciones medicamentosas)

  • Prilocaína y adrenalinaanestésico localModerada

    …ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine The administration… (etiqueta de Prilocaína y adrenalina, Interacciones medicamentosas)

  • RifapentinaantibióticoModerada

    …quinidine, tocainide Antibiotics Chloramphenicol, clarithromycin, dapsone, doxycycline; Fluoroquinolones (such as ciprofloxacin) Oral Anticoagulants Warfarin Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol… (etiqueta de Rifapentina, Interacciones medicamentosas)

  • Ropivacaínaanestésico localModerada

    …ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine NAROPIN should be… (etiqueta de Ropivacaína, Interacciones medicamentosas)

Menciones leves (3)

  • PirimetaminaantipalúdicoLeve

    Drug Interactions: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. (etiqueta de Pirimetamina, Interacciones medicamentosas)

  • QuinidinaantiarrítmicoLeve

    Pediatric use In antimalarial trials, quinidine was as safe and effective in pediatric patients as in adults. (etiqueta de Quinidina, Precauciones)

  • QuininaantipalúdicoLeve

    Other antimalarials (e.g., halofantrine, mefloquine). (etiqueta de Quinina, Interacciones medicamentosas)

Compruebe Tafenoquina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.